Literature DB >> 9633594

The fibronectin-like domain is required for the type V and XI collagenolytic activity of gelatinase B.

T J O'Farrell1, T Pourmotabbed.   

Abstract

Gelatinase B (matrix metalloproteinase-9) is able to degrade several extracellular matrix proteins, including gelatin, elastin, and collagen types IV, V, XI, and XIV. This enzyme contains a "fibronectin-like" domain which is composed of three tandem copies of a fibronectin type 2 homology unit inserted into its catalytic domain. We have studied the involvement of this domain in the substrate specificity of gelatinase B by expressing a mutant of the enzyme, in Escherichia coli, in which this domain has been deleted. This mutant enzyme retained its ability to cleave the peptide substrate Mca-PLGL(Dpa)AR-NH2, possessing K(m) and kcat values similar to those of the wild-type enzyme. In addition, the NH2-terminal, 14-kDa, inhibitory domain of recombinant tissue inhibitor of metalloproteinase-2 was able to inhibit the mutant and the wild-type enzymes with the same potency. The mutant's gelatinolytic activity was also retained but reduced in comparison to that of the wild-type enzyme. However, contrary to the wild-type enzyme, the mutant was not able to digest or bind fibrillar collagen types V and XI. These data indicate that the fibronectin-like domain of gelatinase B is an important determinant of the enzyme's fibrillar collagen substrate specificity. It allows the enzyme to bind to and cleave collagen types V and XI, events which are thought to be involved in several normal physiological and pathological processes such as metastasis and arthritis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9633594     DOI: 10.1006/abbi.1998.0662

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  16 in total

Review 1.  Matrix metalloproteinase collagenolysis in health and disease.

Authors:  Sabrina Amar; Lyndsay Smith; Gregg B Fields
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-04-26       Impact factor: 4.739

2.  Functional basis for the overlap in ligand interactions and substrate specificities of matrix metalloproteinases-9 and -2.

Authors:  Xiaoping Xu; Zhihua Chen; Yao Wang; Yoshishige Yamada; Bjorn Steffensen
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

3.  Remote exosites of the catalytic domain of matrix metalloproteinase-12 enhance elastin degradation.

Authors:  Yan G Fulcher; Steven R Van Doren
Journal:  Biochemistry       Date:  2011-10-11       Impact factor: 3.162

Review 4.  Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.

Authors:  Vanessa J Craig; Li Zhang; James S Hagood; Caroline A Owen
Journal:  Am J Respir Cell Mol Biol       Date:  2015-11       Impact factor: 6.914

5.  NMR and bioinformatics discovery of exosites that tune metalloelastase specificity for solubilized elastin and collagen triple helices.

Authors:  Mark O Palmier; Yan G Fulcher; Rajagopalan Bhaskaran; Vinh Q Duong; Gregg B Fields; Steven R Van Doren
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

6.  Direct visualization of protease action on collagen triple helical structure.

Authors:  Gabriel Rosenblum; Philippe E Van den Steen; Sidney R Cohen; Arkady Bitler; David D Brand; Ghislain Opdenakker; Irit Sagi
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

7.  Selective modulation of matrix metalloproteinase 9 (MMP-9) functions via exosite inhibition.

Authors:  Janelle L Lauer-Fields; John K Whitehead; Shunzi Li; Robert P Hammer; Keith Brew; Gregg B Fields
Journal:  J Biol Chem       Date:  2008-05-22       Impact factor: 5.157

Review 8.  Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites.

Authors:  Christopher M Overall
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

Review 9.  Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.

Authors:  Andriy Yabluchanskiy; Yonggang Ma; Rugmani Padmanabhan Iyer; Michael E Hall; Merry L Lindsey
Journal:  Physiology (Bethesda)       Date:  2013-11

10.  Biosynthesis of promatrix metalloproteinase-9/chondroitin sulphate proteoglycan heteromer involves a Rottlerin-sensitive pathway.

Authors:  Nabin Malla; Eli Berg; Ugo Moens; Lars Uhlin-Hansen; Jan-Olof Winberg
Journal:  PLoS One       Date:  2011-06-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.